April 24, 2021
5 min watch
Save
VIDEO: Roflumilast foam well tolerated, effective in patients with scalp psoriasis
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video from AAD VMX 2021, Kim A. Papp, MD, discusses a recent study investigating safety and efficacy of once-daily roflumilast foam 0.3% in patients with scalp and body psoriasis.